Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Number of new U.S. drug shortages hits lowest level in 20 years
The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
We’re reading about Canada speeding drug reviews, Novo ads
Rise and shine, everyone, another busy day is headed your way. And it is getting off to a…
Secretive Project Prometheus takes VC Bob Nelsen beyond just health care
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
Epic says nearly 300,000 patient records were accessed illegally, in a new lawsuit
Epic Systems, the company behind the largest electronic health records system in medicine, is suing health information network…
Investor Noubar Afeyan warns against a backlash to science in the U.S.
SAN FRANCISCO — Noubar Afeyan, one of biotech’s top investors, warned in an annual letter that a backlash…
More patients are ordering lab tests online, frustrating some doctors
About a decade ago, 48-year-old Darren Sidaway started having health concerns he didn’t think he could bring to…
FDA relaxes oversight of AI-enabled devices and wearables
Food and Drug Administration Commissioner Marty Makary.ANDREW CABALLERO-REYNOLDS/AFP via Getty Images Lizzy Lawrence leads STAT’s coverage of the…
Brain-computer implants are coming of age. 3 trends to watch in 2026
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…